Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Does k-11706 enhance performance and why?

S Imagawa1, K Matsumoto, M Horie

  • 1Doctoral Program of Sports Medicine, GSCHS, University of Tsukuba, Tsukuba, Japan. ima3sytag8sr@md.tsukuba.ac.jp

International Journal of Sports Medicine
|May 15, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Negative regulation of hepatocyte growth factor gene expression in human lung fibroblasts and leukemic cells by transforming growth factor-beta 1 and glucocorticoids.

The Journal of biological chemistry·1992
Same author

Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the finger domain.

Thrombosis and haemostasis·1992
Same author

Rapid and marked induction of hepatocyte growth factor during liver regeneration after ischemic or crush injury.

Hepatology (Baltimore, Md.)·1992
Same author

[Clinical manifestation and prognosis of respiratory syncytial virus infection in infants].

Arerugi = [Allergy]·1992
Same author

Sensitive period for the induction of endoreduplication by rotenone in cultured Chinese hamster cells.

Chromosoma·1992
Same author

Ki-67 antibody labeling index in colorectal carcinoma.

Journal of clinical gastroenterology·1992
Same journal

Improving assessment of post-exercise hypotension as a predictor of training efficacy.

International journal of sports medicine·2026
Same journal

Neuromuscular electrical stimulation after anterior cruciate ligament reconstruction.

International journal of sports medicine·2026
Same journal

Exercise Intensity Effects on Irisin in Master Athletes and Links With Maximal Oxygen Uptake and Body Fat.

International journal of sports medicine·2026
Same journal

Evolution of the Australian Institute of Sport Supplement Program over the last 25 years.

International journal of sports medicine·2026
Same journal

Preseason Passive Torque Asymmetries in Soccer Players with Hamstring Strain Injury.

International journal of sports medicine·2026
Same journal

Musculoskeletal Burden in German Equestrians: Hip-Specific Symptoms and Risk Factors.

International journal of sports medicine·2026
See all related articles

K-11706 enhances erythropoietin (Epo) and hemoglobin production by modulating GATA and hypoxia-inducible factor 1 (HIF-1) activity. This drug improved endurance performance in mice without altering muscle fiber type.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Exercise Physiology

Background:

  • Erythropoietin (Epo) gene expression is regulated by hypoxia-inducible factor 1 (HIF-1) activation and GATA inhibition.
  • Modulating these factors could enhance Epo production, hemoglobin concentration, and potentially endurance performance.
  • The specific effects and mechanisms of drugs targeting these pathways on performance remain largely unexplored.

Purpose of the Study:

  • To investigate the effects of K-11706 on Epo and hemoglobin concentrations, hematocrit, and endurance performance in mice.
  • To explore the potential impact of K-11706 on muscle fiber characteristics.
  • To elucidate the molecular mechanism of K-11706 on GATA and HIF-1 activity.

Main Methods:

  • In vitro studies using Hep3B cells to assess K-11706's effect on GATA and HIF-1 binding activity.

Related Experiment Videos

  • In vivo studies administering K-11706 to mice (n=40) via oral gavage for five or eight days.
  • Assessment of endurance performance using treadmill tests and analysis of muscle fiber types (I, IIA, IIB) from quadriceps biopsies.

    • Main Results:

    • K-11706 inhibited GATA binding activity and enhanced HIF-1 binding activity in Hep3B cells without altering protein expression levels.
    • Administration of K-11706 (3 mg/kg) significantly increased erythropoietin, hemoglobin concentrations, and hematocrit in mice.
    • Significant improvements in endurance performance were observed in mice treated with K-11706, with no changes in muscle fiber cross-sectional diameters or type ratios.

    Conclusions:

    • K-11706 effectively modulates Epo and hemoglobin levels, leading to enhanced endurance performance in mice.
    • The drug's mechanism involves influencing GATA and HIF-1 binding activities rather than altering their protein expression.
    • K-11706 presents a potential therapeutic strategy for improving erythropoiesis and exercise capacity without adverse effects on muscle structure.